Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and thank you for joining the Selective Biosciences first quarter 2023 earnings call. At this time, all participants are in a listen-only mode. Following management's remarks, we will hold a question and answer session. At that time, lines will be open for you. If anyone should require operator assistance, please press star then zero on your touch-tone phone. I would now like to turn the call over to Blaine Davis, Chief Financial Officer at Selecta. Please go ahead. Thank you, and good morning, everyone. Welcome to our first quarter 2023 financial results and business update conference call. The press release reporting our financial results is available in the investor and media section of Selecta's website at www.selectabio.com. and in our quarterly report on Form 10-Q for the quarter ended March 31st, 2023, which was filed earlier this morning with the Securities and Exchange Commission of the SEC. Joining me on today's call are Karsten Brunn, President and Chief Executive Officer, Kay Kishimoto, Chief Scientific Officer, and Peter Traber, our Chief Medical Officer. During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, our financial projections, and our future expectations, plans, partnerships, and prospects. These statements are subject to various risks that are described in the filings made with the SEC, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q. You are cautioned not to place undue reliance on these forward-looking statements, which speak only, as of today, May 4, 2023, and selected disclaims any obligation to update such statements, except as...